Enhabit, Inc. (EHAB)
NYSE: EHAB · IEX Real-Time Price · USD
8.76
+0.01 (0.11%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Enhabit Market Cap
Enhabit has a market cap or net worth of $439.37 million as of July 2, 2024. Its market cap has decreased by -27.04% in one year.
Market Cap
439.37M
Enterprise Value
1.01B
1-Year Change
-27.04%
Ranking
Category
Stock Price
$8.76
Market Cap Chart
Since July 1, 2022, Enhabit's market cap has decreased from $1.13B to $439.37M, a decrease of -61.28%. That is a compound annual growth rate of -37.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 438.90M | -15.40% |
| Dec 29, 2023 | 518.80M | -20.55% |
| Dec 30, 2022 | 653.00M | -42.45% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| biote | 459.07M |
| Taysha Gene Therapies | 455.12M |
| Avid Bioservices | 451.98M |
| LENZ Therapeutics | 451.71M |
| Terns Pharmaceuticals | 443.04M |
| OmniAb | 438.05M |
| EyePoint Pharmaceuticals | 432.82M |
| Voyager Therapeutics | 427.53M |